Affiliation:
1. CQM—Centro de Química da Madeira, NPRG, Universidade da Madeira, Campus da Penteada, 9020-105 Funchal, Portugal
2. Departamento de Química, Faculdade de Ciências Exatas e Engenharia, Universidade da Madeira, Campus da Penteada, 9020-105 Funchal, Portugal
Abstract
Neurodegenerative disorders (NDDs) such as Alzheimer’s (AD) and Parkinson’s (PD) are on the rise, robbing people of their memories and independence. While risk factors such as age and genetics play an important role, exciting studies suggest that a diet rich in foods from plant origin may offer a line of defense. These kinds of foods, namely fruits and vegetables, are packed with a plethora of powerful bioactive secondary metabolites (SBMs), including terpenoids, polyphenols, glucosinolates, phytosterols and capsaicinoids, which exhibit a wide range of biological activities including antioxidant, antidiabetic, antihypertensive, anti-Alzheimer’s, antiproliferative, and antimicrobial properties, associated with preventive effects in the development of chronic diseases mediated by oxidative stress such as type 2 diabetes mellitus, respiratory diseases, cancer, cardiovascular diseases, and NDDs. This review explores the potential of SBMs as theravention agents (metabolites with therapeutic and preventive action) against NDDs. By understanding the science behind plant-based prevention, we may be able to develop new strategies to promote brain health and prevent the rise in NDDs. The proposed review stands out by emphasizing the integration of multiple SBMs in plant-based foods and their potential in preventing NDDs. Previous research has often focused on individual compounds or specific foods, but this review aims to present a comprehensive fingerprint of how a diet rich in various SBMs can synergistically contribute to brain health. The risk factors related to NDD development and the diagnostic process, in addition to some examples of food-related products and medicinal plants that significantly reduce the inhibition of acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and β-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1), are highlighted.
Funder
FCT-Fundação para a Ciência e a Tecnologia
ARDITI-Agência Regional para o Desenvolvimento da Investigação Tecnologia e Inovação
Reference139 articles.
1. Dementia Epidemiology Fact Sheet 2022;Shin;Ann. Rehabil. Med.,2022
2. Silva, M.V.F., Loures, C.d.M.G., Alves, L.C.V., de Souza, L.C., Borges, K.B.G., and das Graças Carvalho, M. (2019). Alzheimer’s Disease: Risk Factors and Potentially Protective Measures. J. Biomed. Sci., 26.
3. Alzheimer Disease;Knopman;Nat. Rev. Dis. Primers,2021
4. Parkinson’s Disease;Bloem;Lancet,2021
5. Parkinson’s Disease;Reich;Med. Clin. North. Am.,2019